Skip to content

Allogene Therapeutics, Inc.

ALLO Nasdaq SEC CIK 1737287

Follow Allogene Therapeutics Weekly email: filings, results, news

News

2 stories filed under Allogene Therapeutics

Allogene Therapeutics: Is The Market Looking At CAR-T Persistence The Wrong Way?

Markets 27 d ago also on CAR

Allogene Therapeutics, Inc. (ALLO) Q2 2026 Earnings Call Transcript

Earnings 43 d ago

Profile

Headquarters: SOUTH SAN FRANCISCO, CA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Latest filings

Q2 2026 report10-Q · 12 Aug 2026

Peers

Where this page comes from

Profile · SEC EDGAR

Financials · SEC EDGAR filing dates

News · 2 stories clustered from the RSS aggregator